Calm Plus
FDA Label NDC 62795-1115

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Medinatura Inc for the product Calm Plus (NDC 62795-1115). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warnings, keep out of reach of children, uses, active ingredients, inactive ingredients, directions, purpose, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Warnings

WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

If symptoms persist or worsen, or if sleeplessness persists continuously for more than 2 weeks, consult your doctor.

Insomnia may be a symptom of serious underlying medical illness.

Do not use if sensitivity to Calm Plus or any of its ingredients exists. In case of accidental overdose, contact a Poison Control Center immediately.

Keep Out Of Reach Of Children

KEEP OUT OF REACH OF CHILDREN

Uses

For the temporary relief of:

• Simple nervous tension

• Restlessness

• Trouble sleeping

Active Ingredients

Active Ingredients:

Each tablet contains equal parts of Avena sativa 2X; Chamomilla 2X; Humulus lupulus 2X; Passiflora incarnata 2X; Calcarea phosphorica 6X; Kali phosphoricum 6X; Kali sulphuricum 6X; Magnesia phosphorica 6X; Natrum muriaticum 6X; Natrum sulphuricum 6X; Zincum valerianicum 6X; Coffea cruda 12X; Nux vomica 12X; Sulphur 12X

Inactive Ingredients

Inactive Ingredients:

Lactose, Magnesium stearate

Directions

Dosage: Adults 18 and over: 1 tablet sublingually or dissolved completely in mouth 2 to 3 times per day or as directed by a physician.

Purpose

For the temporary relief of:

• Simple nervous tension

• Restlessness

• Trouble sleeping

* Please review the disclaimer below.